CADTH | Evidence Driven
CADTH | Evidence Driven

Off-Label Use of Intravenous Immunoglobulin for Non-Neurological Paraneoplastic Disorders: A Review of Clinical Effectiveness

Details

Files
Project Status:
Completed
Project Line:
Health Technology Review
Project Sub Line:
Summary with Critical Appraisal
Project Number:
RC0988-000

Question


  1. What is the clinical effectiveness of the off-label use of intravenous and subcutaneous immunoglobulin for the treatment of non-neurological paraneoplastic disorders?


Key Message

No studies that met pre-specified eligibility criteria were identified


Files

Off-Label Use of Intravenous Immunoglobulin for Non-Neurological Paraneoplastic Disorders: A Review of Clinical Effectiveness Rapid Response April 30, 2018 View PDF

Related Content

Last Updated : April 30, 2018